Zoledronate (Zometa)
Zoledronic acid (Zometa), a new bisphosphonate, has been approved by the FDA for intravenous (IV) treatment of hypercalcemia of malignancy....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Zoledronate (Zometa)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1120
Article Code: 1120b
Date: December 10, 2001
Volume: 43
Pages: 110-111
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1120
Article Code: 1120b
Date: December 10, 2001
Volume: 43
Pages: 110-111
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)